Taku Kikuchi

23PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyMedical mycologyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 03, 2025
Outcomes of elranatamab in relapsed/refractory multiple myeloma: prognostic impact of monocyte count, MyCARe, and R2-ISS.

Taku Kikuchi, Shotaro Sugita, Ukyo Kondo

|Dec 01, 2025
Baseline Cytomegalovirus Immunoglobulin G Levels Predict Reactivation in Patients With Multiple Myeloma Receiving Elranatamab.

Ukyo Kondo, Taku Kikuchi, Shotaro Sugita

|Nov 01, 2025
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.

Taku Kikuchi

|Sep 15, 2025
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.

Takayuki Fujii, Masatoshi Sakurai, Hiroaki Shimizu

|Sep 02, 2025
Identification of a CD138-Negative Therapy-Resistant Subpopulation in Multiple Myeloma with Vulnerability to Splicing Factor Inhibition.

Takahiro Kamiya, Masahiko Ajiro, Motohiko Oshima

|Apr 21, 2025
Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma.

Taku Kikuchi, Miyu Watanabe, Nobuhiro Tsukada

Pageof 4

Frequent Collaborators

2 joint publications

Takehiko Mori

2 joint publications

Keisuke Kataoka

1 joint publications

Rie Yamazaki

1 joint publications

Mamoru Shibata